Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan
Activation of autophagy, via the transcription factor TFEB, is a promising strategy to treat metabolic diseases. Here, the authors report three novel classes of small molecules that promote TFEB nuclear translocation, and provide evidence for the therapeutic efficacy of these compounds in mice and w...
Guardado en:
Autores principales: | Chensu Wang, Hanspeter Niederstrasser, Peter M. Douglas, Rueyling Lin, Juan Jaramillo, Yang Li, Nathaniel W. Oswald, Anwu Zhou, Elizabeth A. McMillan, Saurabh Mendiratta, Zhaohui Wang, Tian Zhao, Zhiqaing Lin, Min Luo, Gang Huang, Rolf A. Brekken, Bruce A. Posner, John B. MacMillan, Jinming Gao, Michael A. White |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81b35dd22d994409b4c733145887247d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan
por: Chensu Wang, et al.
Publicado: (2018) -
Hydralazine targets cAMP-dependent protein kinase leading to sirtuin1/5 activation and lifespan extension in C. elegans
por: Esmaeil Dehghan, et al.
Publicado: (2019) -
Mechatronic system’s permeable materials with controlled porosity
por: Povstyanoy O., et al.
Publicado: (2021) -
mTOR-dependent phosphorylation controls TFEB nuclear export
por: Gennaro Napolitano, et al.
Publicado: (2018) -
UTILIDAD DEL ÍNDICE GLICÉMICO EN NUTRICIÓN DEPORTIVA
por: MacMillan,Norman
Publicado: (2002)